Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Litmus Concepts, Inc., a subsidiary of QuidelOrtho Corp., is an American company located in Santa Clara, CA. The firm develops and manufactures unique diagnostic products for womens health. Quidel Corp., part of QuidelOrtho Corp. since May 2022, acquired Litmus Concepts, Inc. on December 11, 2000 for $19.09 million.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Guangdong New South Artemisia annua Pharmaceutical Co., Ltd., established on 2005-06-27, Business scope includes pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Production of Chinese herbal extracts;Health Consulting Services(Does not include medical services);Chinese herbal medicine planting;Chinese herbal medicine acquisition;wine production;liquor business;Domestic trade agent;Import and export agency;Import and export;Technology Import and Export;Forest tree seed production and management;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Real estate registration agency service;rental service(Licensed rental services not included);Primary processing of edible agricultural products;Retailing of Edible Agricultural Products;Wholesale of edible agricultural products;Purchase of primary agricultural products;tea planting;food,liquor,Beverage and tea production professional equipment manufacturing;food sales;food production;Class III medical device business;Medical Research and Experimental Development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Efamol Ltd., a subsidiary of Infinitus Holdings (Pty) Ltd., is a company headquartered in Hessle, UK, that produces and sells food supplements through online. It was founded in 1977 by David Horrobin. On November 01, 1998 Nutricia Holdings Plc acquired Efamol Ltd. from Scotia Holdings Plc for $27.12 million.\nThe company says this about itself: Efamol specialises in essential fatty acid (EFAs) based products, the so called \"good fats\" that are essential for the healthy functioning of every cell in the human body. These \"good fats\" are from the Omega-3 and Omega-6 families of nutrients and are sourced from high quality fish oils and evening primrose oil.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Kanghua (Shanghai) New Drug Research and Development Co., Ltd., established on 2004-07-09, Business scope includes research and development of new drugs,Production of Unnatural Amino Acids,Fine chemicals such as natural amino acid peptides,Sell ​​self-produced products,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Calspan SRL Corp is a private company headquartered in Buffalo, NY, that designs, markets and operates commercial bulidings and spaces.

Cronex Co., Ltd. is an contract research organization which engages in the provision of research and development services. The company was founded on May 14, 2012 and is headquartered in Hwaseong, South Korea.

Dezhou Luotai Trading Co., Ltd., established on 2018-03-14, Business scope includes general items:Coal and product sales;Sales of building materials;Metal Material Sales;Metal Products Sales;Metal Structure Sales;Sales of non-metallic minerals and products;Non-ferrous metal alloy sales;Sales of high-performance non-ferrous metals and alloy materials;Refined oil wholesale(Free of Hazardous Chemicals);Petroleum product sales(Free of Hazardous Chemicals);Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of renewable resources;Recycling of renewable resources(Removal of productive scrap metal);electronics sales;Machinery sales;Instrument sales;Office Equipment Sales;electric wire,cable management;Hardware retail;Wholesale of hardware products;Sales of building decoration materials;Communication equipment sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Chemical product sales(No licensed chemical products);Sales of electronic special equipment;Arts and crafts and collectibles retail(Except for ivory and its products);Arts and crafts and collectibles wholesale(Except for ivory and its products);Home Appliance Sales;internet sales(Except for products that require a license for sale);Internet equipment sales;Metal Ore Sales;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Art Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan.

Huaibei Yukong Information Technology Co., Ltd., established on 2020-08-10, Business scope includes computer software and hardware,communication device,electric equipment,Research and development of materials and accessories,Sales,Installation and technical service;Technology Information and Management Consulting;Technology project agency service;Science and technology project evaluation service;software development,design service;Patent technology transfer,Technology Development Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Imperial Chemical Industries (ICI) was a British chemical company and was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of leading British chemical companies in 1926. Its headquarters were at Millbank in London, and it was a constituent of the FT 30 and later the FTSE 100 indices.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Part of ProBility Media Corp., Faulk Pharmaceuticals, Inc. is an American company located in Raleigh, NC. The firm develops technology for drug formulations. ProBility Media Corp. acquired Faulk Pharmaceuticals, Inc. on July 16, 2015 for $0.30 million.

Daegu Gyeongbuk Institute of Science and Technology (DGIST) (In Korean 대구경북과학기술원) is a public science and engineering university located in Daegu Metropolitan City, Republic of Korea. Under a Special Act on Support of Scientists and Engineers for Strengthening National Science and Technology Competitiveness, the Korean government enacted Daegu Gyeongbuk Institute of Science and Technology Act (Act No. 6996) and founded DGIST in 2004 as a research institute. In 2008, the act was amended to extend the role of the institute to both research and education, which eventually enabled a transition from a research institute to a university.